US medication costs 300% more than global median

Medication in the U.S. is the most expensive in the world, costing 307% more than the global median, according to a recent study on medication costs around the world.

Behind the U.S., Germany has the second most expensive medications, costing 126% more than the global median, followed by the UAE (122%).

On the other end of the spectrum, Thailand has the lowest-costing medications, about 94% less than the median price, while Kenya’s costs are also around -94%, and Malaysia had costs about 91% below the median.

The study, released by digital healthcare provider Medbelle, was called the Medicine Price Index 2019 and looked at 13 prevalent pharmaceutical compounds that were compared on a dollar-for-dollar basis across 50 countries. The comparisons were conducted regardless of whether medications were covered by a healthcare system or paid directly from the individual’s pocket. Medbelle also recently ranked the best hospital cities in the word in 2019.

The U.S. consistently had the highest costs the world for nearly all the medications––12 out of 13. Only Saudi Arabia had higher costs for one medication­­: Prograf (Tacrolimus), a immunosuppression, transplant rejection prevention medication. For this drug, Saudi Arabia’s cost was 205% higher than the global average.

The U.S. also had significantly higher costs for Lantus (insulin glargine), a drug used to to treat diabetes type I and II. Costs for this drug were 558% higher than the global median. By comparison, the second most expensive country for the same medication, Israel, had costs 193% above the global median. Sky-rocketing insulin prices in the U.S. over the last several years have caused a crisis as individuals needing medication forego the drugs due to unaffordability or have turned to rationing their supplies. Others have even traveled to nearby countries to purchase supplies for themselves and others at a lower price.

“One of the most glaring results of the study is how much higher the cost of medicine is in the United States in comparison to the rest of the world,” Daniel Kolb, co-founder and managing director at Medbelle, said in a statement. “Take Insulin for example; our study shows that Americans pay around five and a half times more than the global median for the life-saving diabetes medication. To put it into perspective, imagine if an everyday item like a gallon of milk cost $3.50 in Canada, but $22.85 across the border in the U.S.”

Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Around the web

Compensation for heart specialists continues to climb. What does this say about cardiology as a whole? Could private equity's rising influence bring about change? We spoke to MedAxiom CEO Jerry Blackwell, MD, MBA, a veteran cardiologist himself, to learn more.

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”